Incheon, South Korea

Jae Kyoung Ko



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jae Kyoung Ko: Innovator in Pharmaceutical Chemistry

Introduction

Jae Kyoung Ko is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on sibutramine compounds. With a total of 3 patents to his name, Ko's inventions have the potential to impact the pharmaceutical industry positively.

Latest Patents

Ko's latest patents include the development of novel inorganic acid salts of sibutramine. These compounds exhibit excellent physicochemical properties and include various crystalline forms. Additionally, he has disclosed pharmaceutical compositions that utilize these compounds as effective ingredients, along with methods for their preparation and application. Another significant patent is the sulphonic acid salt of sibutramine, which also demonstrates favorable physicochemical properties. This patent includes a method for preparing the compound and a pharmaceutical composition that incorporates it.

Career Highlights

Throughout his career, Jae Kyoung Ko has worked with prominent companies such as CJ Corporation and CJ Cheiljedang Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Ko has collaborated with several talented individuals in his field, including Dong Kwon Lim and Eun Young Yang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jae Kyoung Ko is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations in sibutramine compounds. His contributions are poised to make a significant impact in the industry, showcasing the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…